| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/19/2007 | EP1833471A1 External patches containing etofenamate |
| 09/19/2007 | EP1833470A2 Nanoparticles for protein drug delivery |
| 09/19/2007 | EP1833469A2 Pharmaceutical composition of acid labile substances |
| 09/19/2007 | EP1833466A1 Methods for the preparation of stable pharmaceutical solid dosage forms of atorvastatin and amlodipine |
| 09/19/2007 | EP1833462A2 Pharmaceutical manufacturing process for heat sterilised glucocorticoid suspensions |
| 09/19/2007 | EP1833461A1 Pharmaceutical formulations |
| 09/19/2007 | EP1833414A2 Non-irritating compositions containing zinc salts |
| 09/19/2007 | EP1833313A2 Compositions containing high omega-3 and low saturated fatty acid levels |
| 09/19/2007 | EP1833308A1 Increasing the protein concentration of animal organisms |
| 09/19/2007 | EP1833291A1 Method and means for improving bowel health |
| 09/19/2007 | EP1799641A4 Process for the preparation of amorphous fluvastatin sodium |
| 09/19/2007 | EP1750765B1 Antimycobacterial pharmaceutical composition comprising an antitubercular drug |
| 09/19/2007 | EP1749004B1 Pyrrolyl substituted pyrido[2,3-d]pyrimidin-7-ones and derivatives thereof as therapeutic agents |
| 09/19/2007 | EP1732524A4 Methods and compositions for treatment of ion imbalances |
| 09/19/2007 | EP1684702B1 Use of 2-thia-dibenzo[e,h]azulenes for the treatment and prevention of central nervous system diseases and disorders |
| 09/19/2007 | EP1682131B1 Cci-779 for treating mantle cell lymphoma |
| 09/19/2007 | EP1680426B1 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 09/19/2007 | EP1673338B1 Fatty acid compounds, preparation and uses thereof |
| 09/19/2007 | EP1664025B1 Pyrrol derivatives with antibacterial activity |
| 09/19/2007 | EP1655301A4 Cyclic bioisosters of purine system derivatives and a pharmaceutical composition based thereon |
| 09/19/2007 | EP1648563B1 Carbostyril derivatives for accelerating salivation |
| 09/19/2007 | EP1648439A4 Antiglucocorticoid therapy for the prevention of neurological damage in premature infants |
| 09/19/2007 | EP1648433B1 Substituted 2-aminotetralins for the treatment of depressions |
| 09/19/2007 | EP1648422A4 Treatment and preventi0n of cardiovascular events |
| 09/19/2007 | EP1638959B1 5ht -4 -antagonistic 4-(aminomethyl)-piperidine benzamides |
| 09/19/2007 | EP1631298B1 Glycosaminoglycans for treating emotional dysfunctions |
| 09/19/2007 | EP1622867B1 N-(2-phenylethyl)sulfamide derivatives as integrin alpha4 antagonists |
| 09/19/2007 | EP1617817B1 Oral spray to reduce cold symptoms and duration of same |
| 09/19/2007 | EP1594836B1 Hydroxy-tetrahydro-naphthalenylurea derivatives |
| 09/19/2007 | EP1585734A4 Anti-inflammatory medicaments |
| 09/19/2007 | EP1572066A4 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |
| 09/19/2007 | EP1567522B1 Pyrimidine compounds |
| 09/19/2007 | EP1539115B1 Methods and dosage forms for controlled delivery of paliperidone |
| 09/19/2007 | EP1534698B1 Flavonoid compounds as therapeutic antioxidants |
| 09/19/2007 | EP1524985B1 Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated cpg motifs |
| 09/19/2007 | EP1519934B1 Pyrazoloisoquinoline derivatives for inhibiting nf$g(k)b-inducing kinase (nik) |
| 09/19/2007 | EP1515975B1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 09/19/2007 | EP1511719B1 Amide derivatives as inhibitors of the enzymatic activity of renin |
| 09/19/2007 | EP1511517B1 Formulation for parenteral administration of sodium channel blockers |
| 09/19/2007 | EP1499605B1 NF-KappaB INHIBITORS |
| 09/19/2007 | EP1496907B1 Tyrosine kinase inhibitors |
| 09/19/2007 | EP1490335B1 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/19/2007 | EP1480976B1 Thiazole derivatives as npy receptor antagonists |
| 09/19/2007 | EP1478773B1 Methods for assessing acute myeloid leukemia |
| 09/19/2007 | EP1474396B1 N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof |
| 09/19/2007 | EP1471974B1 Tumor necrosis factor combined with interferon in demyelinating diseases |
| 09/19/2007 | EP1439841B1 Androgen receptor modulators and methods of use thereof |
| 09/19/2007 | EP1425011A4 Enhancement of learning and memory and treatment of amnesia |
| 09/19/2007 | EP1408911B1 Sustained-release therapeutic bioadhesive systems |
| 09/19/2007 | EP1407044B1 Rna interference mediating small rna molecules |
| 09/19/2007 | EP1406605B1 Carbamates of 2-heterocyclic-1,2-ethanediols |
| 09/19/2007 | EP1333819B1 Inhalative solution formulation containing a tiotropium salt |
| 09/19/2007 | EP1309590B1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 09/19/2007 | EP1296982B1 1-(heteroaryl-phenyl)-condensed pyrazol derivatives as factor xa inhibitors |
| 09/19/2007 | EP1263803B1 Embolic compositions |
| 09/19/2007 | EP1246611B1 Formulations of active components in the form of a solid dispersion |
| 09/19/2007 | EP1242110B1 Composition for treating prostate cancer |
| 09/19/2007 | EP1198456B1 Potassium channel openers |
| 09/19/2007 | EP1192134B1 Processes for the preparation of (r)-g(a)-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol |
| 09/19/2007 | EP1151009B1 Antimicrobial/endotoxin neutralizing polypeptide |
| 09/19/2007 | EP1127137B1 Lps with reduced toxicity from genetically modified gram negative bacteria |
| 09/19/2007 | EP1069105B1 Capsaicinoide-like substances having ester bond |
| 09/19/2007 | EP1068211B1 Process for purification of a cephalosporin derivative |
| 09/19/2007 | EP0979278B1 Methods for detecting resistance to macrocyclic lactone compounds |
| 09/19/2007 | EP0977767B1 Aminooxy-modified oligonucleotides |
| 09/19/2007 | EP0883608B1 Optical resolution of methylphenidate by 0,0'-bisaroyl tartaric acids |
| 09/19/2007 | EP0714438B1 A novel homeobox factor which stimulates insulin expression in pancreatic islet cells |
| 09/19/2007 | CN101039963A Biotinylated hexadecasaccharides, preparation and use thereof |
| 09/19/2007 | CN101039952A Analogs of 17-hydroxywortmannin as pi3k inhibitors |
| 09/19/2007 | CN101039948A Rapamycin polymorphs and uses thereof |
| 09/19/2007 | CN101039947A Inhibitors of hcv replication |
| 09/19/2007 | CN101039946A Disubstituted pyrazolobenzodiazepines useful as inhibitors for cdk2 and angiogesis, and for the treatment of breast, colon, lung and prostate cancer |
| 09/19/2007 | CN101039945A Pyrazolo[1,5-a]pyrimidine derivatives |
| 09/19/2007 | CN101039944A 1,5-naphthyridine azolidinones having cdk1 antiproliferative activity |
| 09/19/2007 | CN101039943A Novel azaindole thiazolinones as anti-cancer agents |
| 09/19/2007 | CN101039941A Aminopiperidine derivatives, preparation thereof and therapeutic use thereof |
| 09/19/2007 | CN101039940A Tricyclic delta-opioid modulators |
| 09/19/2007 | CN101039939A Quinazolinylmethylene thiazolinones as cdk1 inhibitors |
| 09/19/2007 | CN101039938A Diphenyl substituted alkanes as flap inhibitors |
| 09/19/2007 | CN101039937A Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
| 09/19/2007 | CN101039936A Oxazolo-naphthyl acids as plasminogen activator inhibitor type-1(pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases |
| 09/19/2007 | CN101039935A New piperidine antibiotics |
| 09/19/2007 | CN101039934A 1,5-diheterocycle-1H-triazole derivative |
| 09/19/2007 | CN101039933A Diaminotriazole compounds useful as protein kinase inhibitors |
| 09/19/2007 | CN101039932A Heterocyclic substituted bisarylurea derivatives as kinase inhibitors |
| 09/19/2007 | CN101039930A 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea as crystalline sulfate salt |
| 09/19/2007 | CN101039927A Serotonin 5-HT3 receptor agonist |
| 09/19/2007 | CN101039925A Benzoxazepine derivatives as selective estrogen receptor modulators |
| 09/19/2007 | CN101039921A Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl)oxy]-6-oxopyrimidin-1(6h)-yl]-n-(2-hydroxyethyl)-4-methylbenzamide |
| 09/19/2007 | CN101039919A N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 09/19/2007 | CN101039918A Small molecule modulators of cytokine activity |
| 09/19/2007 | CN101039917A Process for preparing telmisartan |
| 09/19/2007 | CN101039916A Imidazole derivatives as large conductance calcium activated K channel openers |
| 09/19/2007 | CN101039914A Trifluoromethyl substituted benzamide as kinase inhibitors |
| 09/19/2007 | CN101039912A Pyridine derivatives and the preparation and the therapeutic use thereof |
| 09/19/2007 | CN101039911A Polymorph of N,N-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt |
| 09/19/2007 | CN101039910A Donepezil salts suitable for the preparation of pharmaceutical compositions |
| 09/19/2007 | CN101039908A Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 09/19/2007 | CN101039905A New histone deacetylases inhibitors |
| 09/19/2007 | CN101039903A Method and intermediates for the preparation of derivatives of n (1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide |